EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Risk Factors for Gout Flares After Urate-Lowering Therapy: A Nationwide Prospective Cohort Study

Hyunsue Do iD, Chang-Nam Son iD, Hyo Jin Choi iD, Kichul Shin iD, Min Jung Kim iD, In Ah Choi iD, You-Jung Ha iD, Joong Kyong Ahn iD, Sang-Hyon Kim iD, Sung Won Lee iD, Chang Hoon Lee iD, Kyeong Min Son iD und 3 weitere

Journal of Korean Medical Science · 2026 · 41 (43)

DOI: 10.3346/jkms.2026.41.e296 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Korean Medical Science, 2026. Verfasst von Hyunsue Do und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon, Korea. Hauptthemen laut MEDLINE: Gout, Uric Acid, Gout Suppressants. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Patient-Centered Clinical Research Coordinating Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Gout is an inflammatory arthritis caused by the monosodium urate crystal deposition in joints, with some patients experiencing recurrent flares. This study compared the clinical characteristics of patients who experienced gout flares with those who did not. METHODS: Data were analyzed from the Urate Lowering TheRApy in Gout registry, including adults aged ≥ 18 years who met the 2015 American College of Rheumatology/European League Against Rheumatism gout classification criteria. Patients were designated into flare or no-flare groups based on the occurrence of at least one gout flare within the first 6 months. RESULTS: Among 327 patients, 29.0% experienced at least one gout flare within 6 months. Compared with the no-flare group, patients with flares had higher gout impact scale (P = 0.019) and EuroQoL 5-Dimension 3-Level scores (P = 0.012), and more frequent bone erosion (P < 0.001), and tophi (P = 0.031). Multivariate logistic regression showed that radiographic bone erosion (P = 0.013) and poorer quality of life (gout impact scale, P = 0.037; EuroQoL 5-Dimension 3-Level scores, P = 0.014) were independently associated with increased gout flare risk. Fewer patients in the flare group achieved target serum urate levels at 6 months (P = 0.006). CONCLUSION: Impaired quality of life, and radiographic evidence of bone erosion were identified as independent risk factors for gout flare in this prospective cohort study. These findings highlight the importance of comprehensive clinical assessment to identify high-risk patients for future flares and optimize individualized management strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GoutUric AcidGout SuppressantsHumansFemaleMiddle AgedMaleRisk FactorsProspective StudiesAdultAgedQuality of LifeLogistic ModelsRegistriesSymptom Flare Up

Stichwörter der Autor:innen

Clinical FeatureFlareGoutRisk Factor

Substanzen

Uric AcidGout Suppressants

Autor:innen und Institutionen

  • Division of Rheumatology, Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon, Korea.
  • Division of Rheumatology, Department of Internal Medicine, Eulji University School of Medicine, Uijeongbu, Korea.
  • Division of Rheumatology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.
  • Division of Rheumatology, Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Korea.
  • Division of Rheumatology, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
  • Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.

ORCID-Profile: Hyunsue Do, Chang-Nam Son, Hyo Jin Choi, Kichul Shin, Min Jung Kim, In Ah Choi, You-Jung Ha, Joong Kyong Ahn, Sang-Hyon Kim, Sung Won Lee, Chang Hoon Lee, Kyeong Min Son, Hyun-Ok Kim, Se Hee Kim, Ki Won Moon

Förderung

  • Patient-Centered Clinical Research Coordinating Center

Zitieren

APA

Do, H., Son, C. N., Choi, H. J., Shin, K., Kim, M. J., Choi, I. A., Ha, Y. J., Ahn, J. K., Kim, S. H., Lee, S. W., Lee, C. H., Son, K. M., Kim, H. O., Kim, S. H., & Moon, K. W. (2026). Risk Factors for Gout Flares After Urate-Lowering Therapy: A Nationwide Prospective Cohort Study. Journal of Korean Medical Science, 41(43). https://doi.org/10.3346/jkms.2026.41.e296

Vancouver

Do H, Son CN, Choi HJ, Shin K, Kim MJ, Choi IA, et al. Risk Factors for Gout Flares After Urate-Lowering Therapy: A Nationwide Prospective Cohort Study. Journal of Korean Medical Science. 2026;41(43). doi:10.3346/jkms.2026.41.e296

BibTeX
@article{Do2026,
  author = {Do, Hyunsue and Son, Chang-Nam and Choi, Hyo Jin and Shin, Kichul and Kim, Min Jung and Choi, In Ah and Ha, You-Jung and Ahn, Joong Kyong and Kim, Sang-Hyon and Lee, Sung Won and Lee, Chang Hoon and Son, Kyeong Min and Kim, Hyun-Ok and Kim, Se Hee and Moon, Ki Won},
  title = {Risk Factors for Gout Flares After Urate-Lowering Therapy: A Nationwide Prospective Cohort Study},
  journal = {Journal of Korean Medical Science},
  year = {2026},
  volume = {41},
  number = {43},
  doi = {10.3346/jkms.2026.41.e296}
}
Kostenlos starten →